Analyst Price Targets — ESTA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 15, 2026 11:24 am | Anthony Petrone | Mizuho Securities | $105.00 | $86.59 | TheFly | Establishment Labs price target raised to $105 from $100 at Mizuho |
| December 31, 2025 9:24 am | Sam Eiber | BTIG | $86.00 | $72.92 | StreetInsider | Establishment Labs Inc. (ESTA) PT Raised to $86 at BTIG |
| December 17, 2025 12:14 pm | — | Canaccord Genuity | $85.00 | $74.15 | TheFly | Establishment Labs price target raised to $85 from $72 at Canaccord |
| December 10, 2025 11:06 am | Mike Matson | Needham | $84.00 | $71.01 | StreetInsider | Establishment Labs Inc. (ESTA) PT Raised to $84 at Needham |
| November 14, 2025 10:39 am | Sam Eiber | BTIG | $81.00 | $64.75 | StreetInsider | Establishment Labs Inc. (ESTA) PT Raised to $81 at BTIG |
| November 6, 2025 11:22 pm | — | Needham | $70.00 | $64.91 | TheFly | Establishment Labs price target raised to $70 from $48 at Needham |
| November 5, 2025 5:20 pm | Sam Eiber | BTIG | $70.00 | $59.55 | StreetInsider | Establishment Labs Inc. (ESTA) PT Raised to $70 at BTIG |
| August 22, 2024 5:50 am | Joanne Wuensch | Citigroup | $45.00 | $44.05 | TheFly | Citi opens 'positive catalyst watch' on Establishment Labs |
| June 6, 2024 6:34 am | Anthony Petrone | Mizuho Securities | $70.00 | $53.89 | StreetInsider | Establishment Labs Inc. (ESTA) PT Raised to $70 at Mizuho |
| April 1, 2024 6:34 am | Anthony Petrone | Mizuho Securities | $65.00 | $50.90 | StreetInsider | Establishment Labs Inc. (ESTA) PT Raised to $65 at Mizuho 'on the potential for US Motiva to receive FDA clearance' |
Latest News for ESTA
JW Asset Management sold 90,533 shares between May 26 and May 28, 2026, generating a transaction value of ~$6.64 million at a weighted average price of around $73.31 per share. The transaction represented 3.04% of the insider's total indirect holdings, reducing indirect ownership from ~2.98 million to ~2.89 million shares.
NEW YORK--(BUSINESS WIRE)---- $ESTA #Breast--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, announced today the appointment of Taylor Harris to its Board of Directors. Mr. Harris brings more than 25 years of experience in corporate finance, executive leadership and board…
NEW YORK--(BUSINESS WIRE)---- $ESTA #Breast--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, will be added as a member of the US small-cap Russell 2000® Index, effective when the US market opens on June 29th as part of the 2026 Russell indexes reconstitution. Membership in the…
Establishment Labs develops advanced silicone implants and medical devices for global plastic surgery markets.
WEST JORDAN, Utah, May 18, 2026 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced the appointment of Raj Denhoy to the role of Chief Financial Officer (CFO) effective today. “Route 92 Medical has built a strong position in neurovascular intervention,” said Raj Denhoy, CFO at Route…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ESTA.
U.S. House Trading
No House trades found for ESTA.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.